Applying antibody-sensitive hypervariable region 1-deleted hepatitis C virus to the study of escape pathways of neutralizing human monoclonal antibody AR5A

被引:26
|
作者
Velazquez-Moctezuma, Rodrigo [1 ,2 ,3 ]
Law, Mansun [4 ]
Bukh, Jens [1 ,2 ,3 ]
Prentoe, Jannick [1 ,2 ,3 ]
机构
[1] Univ Copenhagen, Copenhagen Hepatitis C Program CO HEP, Dept Infect Dis, Copenhagen, Denmark
[2] Univ Copenhagen, Clin Res Ctr, Hvidovre Hosp, Copenhagen, Denmark
[3] Univ Copenhagen, Dept Immunol & Microbiol, Fac Hlth & Med Sci, Copenhagen, Denmark
[4] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA
关键词
B TYPE-I; CELL-CULTURE SYSTEMS; E2; GLYCOPROTEIN; INFECTION; HCV; RECEPTOR; VACCINE; IDENTIFICATION; MUTATIONS; GENOTYPES;
D O I
10.1371/journal.ppat.1006214
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Hepatitis C virus (HCV) is a major cause of end-stage liver diseases. With 3-4 million new HCV infections yearly, a vaccine is urgently needed. A better understanding of virus escape from neutralizing antibodies and their corresponding epitopes are important for this effort. However, for viral isolates with high antibody resistance, or antibodies with moderate potency, it remains challenging to induce escape mutations in vitro. Here, as proof-of-concept, we used antibody-sensitive HVR1-deleted (.HVR1) viruses to generate escape mutants for a human monoclonal antibody, AR5A, targeting a rare cross-genotype conserved epitope. By analyzing the genotype 1a envelope proteins (E1/E2) of recovered CoreNS2 recombinant H77/JFH1(Delta HVR1) and performing reverse genetic studies we found that resistance to AR5A was caused by substitution L665W, also conferring resistance to the parental H77/JFH1. The mutation did not induce viral fitness loss, but abrogated AR5A binding to HCV particles and intracellular E1/E2 complexes. Culturing J6/JFH1(Delta HVR1) (genotype 2a), for which fitness was decreased by L665W, with AR5A generated AR5A-resistant viruses with the substitutions I345V, L665S, and S680T, which we introduced into J6/JFH1 and J6/JFH1(Delta HVR1). I345V increased fitness but had no effect on AR5A resistance. L665S impaired fitness and decreased AR5A sensitivity, while S680T combined with L665S compensated for fitness loss and decreased AR5A sensitivity even further. Interestingly, S680T alone had no fitness effect but sensitized the virus to AR5A. Of note, H77/JFH1(L665S) was non-viable. The resistance mutations did not affect cell-to-cell spread or E1/E2 interactions. Finally, introducing L665W, identified in genotype 1, into genotypes 2-6 parental and HVR1-deleted variants (not available for genotype 4a) we observed diverse effects on viral fitness and a universally pronounced reduction in AR5A sensitivity. Thus, we were able to take advantage of the neutralization-sensitive HVR1-deleted viruses to rapidly generate escape viruses aiding our understanding of the divergent escape pathways used by HCV to evade AR5A.
引用
收藏
页数:29
相关论文
共 50 条
  • [31] A Single Residue within the V5 Region of HIV-1 Envelope Facilitates Viral Escape from the Broadly Neutralizing Monoclonal Antibody VRC01
    Guo, Dongxing
    Shi, Xuanling
    Arledge, Kelly C.
    Song, Dingka
    Jiang, Liwei
    Fu, Lili
    Gong, Xinqi
    Zhang, Senyan
    Wang, Xinquan
    Zhang, Linqi
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (51) : 43170 - 43179
  • [32] Fine definition of the epitope on the gp41 glycoprotein of human immunodeficiency virus type 1 for the neutralizing monoclonal antibody 2F5
    Parker, CE
    Deterding, LJ
    Hager-Braun, C
    Binley, JM
    Schülke, N
    Katinger, H
    Moore, JP
    Tomer, KB
    JOURNAL OF VIROLOGY, 2001, 75 (22) : 10906 - 10911
  • [33] Human immunodeficiency virus type 1-neutralizing monoclonal antibody 2F5 is multispecific for sequences flanking the DKW core epitope
    Menendez, A
    Chow, KC
    Pan, OCC
    Scott, JK
    JOURNAL OF MOLECULAR BIOLOGY, 2004, 338 (02) : 311 - 327
  • [34] CHARACTERIZATION OF A MOUSE HUMAN CHIMERIC MONOCLONAL-ANTIBODY (C-BETA-1) TO A PRINCIPAL NEUTRALIZING DOMAIN OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE PROTEIN
    MATSUSHITA, S
    MAEDA, H
    KIMACHI, K
    EDA, Y
    MAEDA, Y
    MURAKAMI, T
    TOKIYOSHI, S
    TAKATSUKI, K
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (06) : 1107 - 1115
  • [35] A BROADLY NEUTRALIZING MONOCLONAL-ANTIBODY THAT RECOGNIZES THE V3 REGION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GLYCOPROTEIN GP120
    OHNO, T
    TERADA, M
    YONEDA, Y
    SHEA, KW
    CHAMBERS, RF
    STROKA, DM
    NAKAMURA, M
    KUFE, DW
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (23) : 10726 - 10729
  • [36] Determination of the human antibody response to the neutralizing epitopes of glycoproteins E1E2 and its broad cross-genotype neutralizing activity in hepatitis C virus infection
    Liu, Ruyu
    Rao, Huiying
    Jiang, Dong
    Wang, Jianghua
    Guo, Zhongsheng
    Wei, Lai
    HEPATOLOGY, 2012, 56 : 1113A - 1113A
  • [37] GENERATION OF A HUMAN MONOCLONAL-ANTIBODY TO HEPATITIS-C VIRUS, JRA1, BY ACTIVATION OF PERIPHERAL-BLOOD LYMPHOCYTES AND HYPOOSMOLAR ELECTROFUSION
    ZIMMERMANN, U
    LOVEHOMAN, L
    GESSNER, P
    CLARK, D
    KLOCK, G
    JOHLIN, FC
    NEIL, GA
    HEPATOLOGY, 1993, 18 (04) : A265 - A265
  • [38] Impact of V2 mutations on escape from a potent neutralizing anti-V3 monoclonal antibody during in vitro selection of a primary human immunodeficiency virus type 1 isolate
    Shibata, Junji
    Yoshimura, Kazuhisa
    Honda, Akiko
    Koito, Atsushi
    Murakami, Toshio
    Matsushita, Shuzo
    JOURNAL OF VIROLOGY, 2007, 81 (08) : 3757 - 3768
  • [39] Development of a tier 1 R5 clade C simian-human immunodeficiency virus as a tool to test neutralizing antibody-based immunoprophylaxis
    Siddappa, Nagadenahalli B.
    Hemashettar, Girish
    Wong, Yin Ling
    Lakhashe, Samir
    Rasmussen, Robert A.
    Watkins, Jennifer D.
    Novembre, Francis J.
    Villinger, Francois
    Else, James G.
    Montefiori, David C.
    Ruprecht, Ruth M.
    JOURNAL OF MEDICAL PRIMATOLOGY, 2011, 40 (02) : 120 - 128
  • [40] Ontogeny of hepatitis C virus (HCV) hypervariable region 1 (HVR1) heterogeneity and HVR1 antibody responses over a 3 year period in a patient infected with HCV type 2b
    Majid, A
    Jackson, P
    Lawal, Z
    Pearson, GMJ
    Parker, H
    Alexander, GJM
    Allain, JP
    Petrik, J
    JOURNAL OF GENERAL VIROLOGY, 1999, 80 : 317 - 325